nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.207	0.229	CbGbCtD
Halofantrine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.107	0.118	CbGbCtD
Halofantrine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.104	0.114	CbGbCtD
Halofantrine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0995	0.11	CbGbCtD
Halofantrine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0809	0.0894	CbGbCtD
Halofantrine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0694	0.0767	CbGbCtD
Halofantrine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0685	0.0757	CbGbCtD
Halofantrine—CYP3A4—Prednisone—ankylosing spondylitis	0.0647	0.0715	CbGbCtD
Halofantrine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0635	0.0702	CbGbCtD
Halofantrine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0404	0.0446	CbGbCtD
Halofantrine—Haematocrit decreased—Methotrexate—ankylosing spondylitis	0.00273	0.0286	CcSEcCtD
Halofantrine—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.00149	0.0156	CcSEcCtD
Halofantrine—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00137	0.0144	CcSEcCtD
Halofantrine—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.00137	0.0143	CcSEcCtD
Halofantrine—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00124	0.013	CcSEcCtD
Halofantrine—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00124	0.013	CcSEcCtD
Halofantrine—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00108	0.0114	CcSEcCtD
Halofantrine—Abdominal distension—Prednisolone—ankylosing spondylitis	0.00106	0.0111	CcSEcCtD
Halofantrine—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.000983	0.0103	CcSEcCtD
Halofantrine—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.000974	0.0102	CcSEcCtD
Halofantrine—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.000971	0.0102	CcSEcCtD
Halofantrine—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000906	0.00949	CcSEcCtD
Halofantrine—Face oedema—Prednisone—ankylosing spondylitis	0.000854	0.00894	CcSEcCtD
Halofantrine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000811	0.0085	CcSEcCtD
Halofantrine—Abdominal distension—Prednisone—ankylosing spondylitis	0.000769	0.00806	CcSEcCtD
Halofantrine—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000754	0.0079	CcSEcCtD
Halofantrine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000752	0.00788	CcSEcCtD
Halofantrine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000744	0.0078	CcSEcCtD
Halofantrine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000692	0.00724	CcSEcCtD
Halofantrine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00069	0.00723	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00068	0.00712	CcSEcCtD
Halofantrine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000677	0.00709	CcSEcCtD
Halofantrine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000677	0.00709	CcSEcCtD
Halofantrine—Malaise—Prednisolone—ankylosing spondylitis	0.000661	0.00692	CcSEcCtD
Halofantrine—Back pain—Triamcinolone—ankylosing spondylitis	0.000652	0.00683	CcSEcCtD
Halofantrine—Convulsion—Prednisolone—ankylosing spondylitis	0.000635	0.00665	CcSEcCtD
Halofantrine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000627	0.00657	CcSEcCtD
Halofantrine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000627	0.00657	CcSEcCtD
Halofantrine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000625	0.00655	CcSEcCtD
Halofantrine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000624	0.00653	CcSEcCtD
Halofantrine—Discomfort—Prednisolone—ankylosing spondylitis	0.000616	0.00646	CcSEcCtD
Halofantrine—Malaise—Triamcinolone—ankylosing spondylitis	0.000608	0.00637	CcSEcCtD
Halofantrine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000606	0.00635	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000598	0.00626	CcSEcCtD
Halofantrine—Cough—Triamcinolone—ankylosing spondylitis	0.000588	0.00616	CcSEcCtD
Halofantrine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000584	0.00612	CcSEcCtD
Halofantrine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000583	0.0061	CcSEcCtD
Halofantrine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000574	0.00601	CcSEcCtD
Halofantrine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000572	0.006	CcSEcCtD
Halofantrine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000572	0.006	CcSEcCtD
Halofantrine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000567	0.00594	CcSEcCtD
Halofantrine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000567	0.00594	CcSEcCtD
Halofantrine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000567	0.00594	CcSEcCtD
Halofantrine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000566	0.00592	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000555	0.00581	CcSEcCtD
Halofantrine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000553	0.0058	CcSEcCtD
Halofantrine—Malaise—Betamethasone—ankylosing spondylitis	0.000551	0.00578	CcSEcCtD
Halofantrine—Malaise—Dexamethasone—ankylosing spondylitis	0.000551	0.00578	CcSEcCtD
Halofantrine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00055	0.00576	CcSEcCtD
Halofantrine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000549	0.00575	CcSEcCtD
Halofantrine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000546	0.00572	CcSEcCtD
Halofantrine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000537	0.00562	CcSEcCtD
Halofantrine—Convulsion—Betamethasone—ankylosing spondylitis	0.00053	0.00555	CcSEcCtD
Halofantrine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00053	0.00555	CcSEcCtD
Halofantrine—Myalgia—Betamethasone—ankylosing spondylitis	0.000521	0.00545	CcSEcCtD
Halofantrine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000521	0.00545	CcSEcCtD
Halofantrine—Discomfort—Betamethasone—ankylosing spondylitis	0.000514	0.00539	CcSEcCtD
Halofantrine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000514	0.00539	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000501	0.00525	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.0005	0.00524	CcSEcCtD
Halofantrine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000499	0.00523	CcSEcCtD
Halofantrine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000499	0.00523	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000494	0.00518	CcSEcCtD
Halofantrine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000494	0.00517	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000493	0.00516	CcSEcCtD
Halofantrine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000493	0.00516	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000493	0.00516	CcSEcCtD
Halofantrine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000484	0.00507	CcSEcCtD
Halofantrine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000483	0.00506	CcSEcCtD
Halofantrine—Malaise—Prednisone—ankylosing spondylitis	0.00048	0.00503	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000477	0.00499	CcSEcCtD
Halofantrine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000476	0.00498	CcSEcCtD
Halofantrine—Anorexia—Betamethasone—ankylosing spondylitis	0.000476	0.00498	CcSEcCtD
Halofantrine—Urticaria—Prednisolone—ankylosing spondylitis	0.000475	0.00498	CcSEcCtD
Halofantrine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000474	0.00497	CcSEcCtD
Halofantrine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000473	0.00496	CcSEcCtD
Halofantrine—Convulsion—Prednisone—ankylosing spondylitis	0.000461	0.00483	CcSEcCtD
Halofantrine—Chills—Methotrexate—ankylosing spondylitis	0.000459	0.0048	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000455	0.00476	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000455	0.00476	CcSEcCtD
Halofantrine—Arthralgia—Prednisone—ankylosing spondylitis	0.000453	0.00475	CcSEcCtD
Halofantrine—Myalgia—Prednisone—ankylosing spondylitis	0.000453	0.00475	CcSEcCtD
Halofantrine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000453	0.00475	CcSEcCtD
Halofantrine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000452	0.00474	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000449	0.0047	CcSEcCtD
Halofantrine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000448	0.00469	CcSEcCtD
Halofantrine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000448	0.00469	CcSEcCtD
Halofantrine—Discomfort—Prednisone—ankylosing spondylitis	0.000448	0.00469	CcSEcCtD
Halofantrine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000439	0.0046	CcSEcCtD
Halofantrine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000439	0.0046	CcSEcCtD
Halofantrine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000437	0.00458	CcSEcCtD
Halofantrine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000436	0.00457	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000435	0.00455	CcSEcCtD
Halofantrine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000434	0.00454	CcSEcCtD
Halofantrine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000434	0.00454	CcSEcCtD
Halofantrine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000434	0.00454	CcSEcCtD
Halofantrine—Back pain—Methotrexate—ankylosing spondylitis	0.00043	0.00451	CcSEcCtD
Halofantrine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00043	0.00451	CcSEcCtD
Halofantrine—Fatigue—Betamethasone—ankylosing spondylitis	0.00043	0.00451	CcSEcCtD
Halofantrine—Anorexia—Prednisone—ankylosing spondylitis	0.000414	0.00434	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000413	0.00432	CcSEcCtD
Halofantrine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000411	0.00431	CcSEcCtD
Halofantrine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000411	0.00431	CcSEcCtD
Halofantrine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000408	0.00427	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000408	0.00427	CcSEcCtD
Halofantrine—Malaise—Methotrexate—ankylosing spondylitis	0.000401	0.0042	CcSEcCtD
Halofantrine—Urticaria—Betamethasone—ankylosing spondylitis	0.000396	0.00415	CcSEcCtD
Halofantrine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000396	0.00415	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000396	0.00415	CcSEcCtD
Halofantrine—Dizziness—Prednisolone—ankylosing spondylitis	0.000395	0.00414	CcSEcCtD
Halofantrine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000395	0.00413	CcSEcCtD
Halofantrine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000394	0.00413	CcSEcCtD
Halofantrine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000394	0.00413	CcSEcCtD
Halofantrine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000394	0.00412	CcSEcCtD
Halofantrine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00039	0.00409	CcSEcCtD
Halofantrine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000389	0.00408	CcSEcCtD
Halofantrine—Cough—Methotrexate—ankylosing spondylitis	0.000388	0.00407	CcSEcCtD
Halofantrine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000388	0.00407	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—ankylosing spondylitis	0.000386	0.00404	CcSEcCtD
Halofantrine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000383	0.00401	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000379	0.00397	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—ankylosing spondylitis	0.000379	0.00397	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—ankylosing spondylitis	0.000379	0.00397	CcSEcCtD
Halofantrine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000378	0.00396	CcSEcCtD
Halofantrine—Rash—Prednisolone—ankylosing spondylitis	0.000377	0.00395	CcSEcCtD
Halofantrine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000377	0.00395	CcSEcCtD
Halofantrine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000375	0.00393	CcSEcCtD
Halofantrine—Fatigue—Prednisone—ankylosing spondylitis	0.000375	0.00392	CcSEcCtD
Halofantrine—Headache—Prednisolone—ankylosing spondylitis	0.000375	0.00392	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—ankylosing spondylitis	0.000374	0.00392	CcSEcCtD
Halofantrine—Constipation—Prednisone—ankylosing spondylitis	0.000372	0.00389	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—ankylosing spondylitis	0.000366	0.00384	CcSEcCtD
Halofantrine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000364	0.00381	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000363	0.0038	CcSEcCtD
Halofantrine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000363	0.0038	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000358	0.00375	CcSEcCtD
Halofantrine—Asthenia—Betamethasone—ankylosing spondylitis	0.000358	0.00375	CcSEcCtD
Halofantrine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000358	0.00375	CcSEcCtD
Halofantrine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000355	0.00372	CcSEcCtD
Halofantrine—Nausea—Prednisolone—ankylosing spondylitis	0.000355	0.00372	CcSEcCtD
Halofantrine—Pruritus—Betamethasone—ankylosing spondylitis	0.000353	0.0037	CcSEcCtD
Halofantrine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000353	0.0037	CcSEcCtD
Halofantrine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00035	0.00366	CcSEcCtD
Halofantrine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000349	0.00365	CcSEcCtD
Halofantrine—Rash—Triamcinolone—ankylosing spondylitis	0.000347	0.00363	CcSEcCtD
Halofantrine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000346	0.00363	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—ankylosing spondylitis	0.000346	0.00363	CcSEcCtD
Halofantrine—Rash—Methylprednisolone—ankylosing spondylitis	0.000346	0.00362	CcSEcCtD
Halofantrine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000346	0.00362	CcSEcCtD
Halofantrine—Urticaria—Prednisone—ankylosing spondylitis	0.000345	0.00362	CcSEcCtD
Halofantrine—Headache—Triamcinolone—ankylosing spondylitis	0.000345	0.00361	CcSEcCtD
Halofantrine—Headache—Methylprednisolone—ankylosing spondylitis	0.000344	0.0036	CcSEcCtD
Halofantrine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000344	0.0036	CcSEcCtD
Halofantrine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000341	0.00358	CcSEcCtD
Halofantrine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000341	0.00358	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000331	0.00347	CcSEcCtD
Halofantrine—Dizziness—Betamethasone—ankylosing spondylitis	0.00033	0.00346	CcSEcCtD
Halofantrine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00033	0.00346	CcSEcCtD
Halofantrine—Nausea—Triamcinolone—ankylosing spondylitis	0.000327	0.00342	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000326	0.00342	CcSEcCtD
Halofantrine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000326	0.00341	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00032	0.00335	CcSEcCtD
Halofantrine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000317	0.00332	CcSEcCtD
Halofantrine—Vomiting—Betamethasone—ankylosing spondylitis	0.000317	0.00332	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000316	0.00331	CcSEcCtD
Halofantrine—Rash—Dexamethasone—ankylosing spondylitis	0.000315	0.0033	CcSEcCtD
Halofantrine—Rash—Betamethasone—ankylosing spondylitis	0.000315	0.0033	CcSEcCtD
Halofantrine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000314	0.00329	CcSEcCtD
Halofantrine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000314	0.00329	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—ankylosing spondylitis	0.000313	0.00328	CcSEcCtD
Halofantrine—Headache—Betamethasone—ankylosing spondylitis	0.000313	0.00327	CcSEcCtD
Halofantrine—Headache—Dexamethasone—ankylosing spondylitis	0.000313	0.00327	CcSEcCtD
Halofantrine—Asthenia—Prednisone—ankylosing spondylitis	0.000312	0.00327	CcSEcCtD
Halofantrine—Pruritus—Prednisone—ankylosing spondylitis	0.000307	0.00322	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000299	0.00313	CcSEcCtD
Halofantrine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000297	0.00311	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000297	0.00311	CcSEcCtD
Halofantrine—Nausea—Betamethasone—ankylosing spondylitis	0.000296	0.0031	CcSEcCtD
Halofantrine—Nausea—Dexamethasone—ankylosing spondylitis	0.000296	0.0031	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—ankylosing spondylitis	0.000289	0.00302	CcSEcCtD
Halofantrine—Dizziness—Prednisone—ankylosing spondylitis	0.000287	0.00301	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000287	0.00301	CcSEcCtD
Halofantrine—Vomiting—Prednisone—ankylosing spondylitis	0.000276	0.00289	CcSEcCtD
Halofantrine—Rash—Prednisone—ankylosing spondylitis	0.000274	0.00287	CcSEcCtD
Halofantrine—Dermatitis—Prednisone—ankylosing spondylitis	0.000274	0.00287	CcSEcCtD
Halofantrine—Headache—Prednisone—ankylosing spondylitis	0.000272	0.00285	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—ankylosing spondylitis	0.000261	0.00273	CcSEcCtD
Halofantrine—Nausea—Prednisone—ankylosing spondylitis	0.000258	0.0027	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—ankylosing spondylitis	0.000257	0.00269	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000249	0.0026	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—ankylosing spondylitis	0.00024	0.00252	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—ankylosing spondylitis	0.000231	0.00242	CcSEcCtD
Halofantrine—Rash—Methotrexate—ankylosing spondylitis	0.000229	0.0024	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000229	0.0024	CcSEcCtD
Halofantrine—Headache—Methotrexate—ankylosing spondylitis	0.000228	0.00238	CcSEcCtD
Halofantrine—Nausea—Methotrexate—ankylosing spondylitis	0.000216	0.00226	CcSEcCtD
